Related Experiment Video
Updated: Aug 22, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Human Artificial Chromosomes and Their Transfer to Target Cells
S V Ponomartsev1, S A Sinenko1, A N Tomilin1,2
1Institute of Cytology Russian Academy of Sciences, St. Petersburg, 194064 Russia.
Human artificial chromosomes (HACs) are powerful genetic vectors for carrying large DNA. This review covers HAC development, features, applications, and the crucial step of transferring them between cells.
Area of Science:
- * Genetics
- * Molecular Biology
- * Biotechnology
Background:
- * Human artificial chromosomes (HACs) are engineered genetic vectors.
- * They can carry large DNA constructs, including entire gene loci.
- * HACs function as independent genetic elements without integrating into host genomes.
Purpose of the Study:
- * To review the development and construction of HACs.
- * To discuss the structural and functional characteristics of HACs.
- * To explore the applications and cell transfer methods for HAC technology.
Main Methods:
- * Review of existing literature on HAC development and applications.
- * Analysis of HAC construction strategies.
- * Examination of techniques for HAC transfer between cells.
Main Results:
- * HACs offer ultra-high genetic capacity and stable self-maintenance.
- * Various HAC types have been developed with distinct features.
- * Cell transfer remains a technically challenging aspect of HAC technology.
Conclusions:
- * HACs are versatile tools with significant potential in genetic engineering and therapy.
- * Further optimization of HAC construction and transfer is essential for broader application.
- * This review provides a comprehensive overview of HAC technology and its future prospects.
More Related Videos
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
12:09Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019